Luis J. Leandro‐García

3.3k total citations
31 papers, 1.5k citations indexed

About

Luis J. Leandro‐García is a scholar working on Molecular Biology, Oncology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Luis J. Leandro‐García has authored 31 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 11 papers in Oncology and 10 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Luis J. Leandro‐García's work include Renal cell carcinoma treatment (6 papers), Cancer-related Molecular Pathways (6 papers) and Thyroid Cancer Diagnosis and Treatment (6 papers). Luis J. Leandro‐García is often cited by papers focused on Renal cell carcinoma treatment (6 papers), Cancer-related Molecular Pathways (6 papers) and Thyroid Cancer Diagnosis and Treatment (6 papers). Luis J. Leandro‐García collaborates with scholars based in Spain, United States and Sweden. Luis J. Leandro‐García's co-authors include Cristina Rodríguez‐Antona, Mercedes Robledo, Susanna Leskelä, Iñigo Landa, Alberto Cascón, Cristina Montero‐Conde, Rocío Letón, Elena López‐Jiménez, Lucía Inglada‐Pérez and Jesús García-Donás and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Clinical Endocrinology & Metabolism and Cancer Research.

In The Last Decade

Luis J. Leandro‐García

31 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Luis J. Leandro‐García Spain	20	781	532	476	322	315	31	1.5k
Susanna Leskelä Spain	22	577 0.7×	457 0.9×	415 0.9×	143 0.4×	227 0.7×	27	1.4k
Cristina Montero‐Conde Spain	20	585 0.7×	389 0.7×	321 0.7×	191 0.6×	542 1.7×	31	1.3k
Kathleen D. Whitney United States	16	775 1.0×	695 1.3×	318 0.7×	135 0.4×	109 0.3×	25	1.6k
John E. Monahan United States	12	918 1.2×	274 0.5×	306 0.6×	561 1.7×	192 0.6×	18	1.6k
Frauke Bentzien United States	10	821 1.1×	665 1.3×	298 0.6×	522 1.6×	248 0.8×	12	2.1k
Rocío Letón Spain	20	457 0.6×	262 0.5×	403 0.8×	119 0.4×	373 1.2×	25	1.3k
Shuko Harada United States	22	604 0.8×	399 0.8×	297 0.6×	293 0.9×	72 0.2×	101	1.4k
Armelle Logié United Kingdom	19	962 1.2×	442 0.8×	433 0.9×	202 0.6×	206 0.7×	33	1.6k
J. W. Clark United States	15	443 0.6×	490 0.9×	331 0.7×	937 2.9×	273 0.9×	26	1.5k
Elena López‐Jiménez Spain	16	529 0.7×	240 0.5×	357 0.8×	66 0.2×	202 0.6×	28	1.1k

Countries citing papers authored by Luis J. Leandro‐García

Since Specialization

Citations

This map shows the geographic impact of Luis J. Leandro‐García's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luis J. Leandro‐García with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luis J. Leandro‐García more than expected).

Fields of papers citing papers by Luis J. Leandro‐García

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luis J. Leandro‐García. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luis J. Leandro‐García. The network helps show where Luis J. Leandro‐García may publish in the future.

Co-authorship network of co-authors of Luis J. Leandro‐García

This figure shows the co-authorship network connecting the top 25 collaborators of Luis J. Leandro‐García. A scholar is included among the top collaborators of Luis J. Leandro‐García based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luis J. Leandro‐García. Luis J. Leandro‐García is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Leandro‐García, Luis J. & Iñigo Landa. (2023). Mechanistic Insights of Thyroid Cancer Progression. Endocrinology. 164(9). 19 indexed citations

Díaz‐Talavera, Alberto, Cristina Montero‐Conde, Luis J. Leandro‐García, & Mercedes Robledo. (2022). PrimPol: A Breakthrough among DNA Replication Enzymes and a Potential New Target for Cancer Therapy. Biomolecules. 12(2). 248–248. 9 indexed citations

Saqcena, Mahesh, Luis J. Leandro‐García, Jesper L.V. Mååg, et al.. (2020). SWI/SNF Complex Mutations Promote Thyroid Tumor Progression and Insensitivity to Redifferentiation Therapies. Cancer Discovery. 11(5). 1158–1175. 71 indexed citations

Coloma, Javier Pardo de Santayana y, Bruna Calsina, María Monteagudo, et al.. (2020). Novel DNMT3A Germline Variant in a Patient with Multiple Paragangliomas and Papillary Thyroid Carcinoma. Cancers. 12(11). 3304–3304. 9 indexed citations

Roldán‐Romero, Juan María, María Santos, Javier Lanillos, et al.. (2020). Molecular characterization of chromophobe renal cell carcinoma reveals mTOR pathway alterations in patients with poor outcome. Modern Pathology. 33(12). 2580–2590. 34 indexed citations

García-Donás, Jesús, Benoit Beuselinck, Lucía Inglada‐Pérez, et al.. (2016). Deep sequencing reveals microRNAs predictive of antiangiogenic drug response. JCI Insight. 1(10). e86051–e86051. 34 indexed citations

Apellániz-Ruiz, María, Miyoung Lee, Lara M. Munín Sánchez, et al.. (2014). Whole-Exome Sequencing Reveals Defective CYP3A4 Variants Predictive of Paclitaxel Dose-Limiting Neuropathy. Clinical Cancer Research. 21(2). 322–328. 58 indexed citations

Rodríguez‐Antona, Cristina, Lucía Inglada‐Pérez, Aguirre A. de Cubas, et al.. (2013). Influence of RET mutations on the expression of tyrosine kinases in medullary thyroid carcinoma. Endocrine Related Cancer. 20(4). 611–619. 17 indexed citations

Leandro‐García, Luis J., Susanna Leskelä, Lucía Inglada‐Pérez, et al.. (2012). Hematologic β-Tubulin VI Isoform Exhibits Genetic Variability That Influences Paclitaxel Toxicity. Cancer Research. 72(18). 4744–4752. 21 indexed citations

10.

Leandro‐García, Luis J., Susanna Leskelä, Carlos Jara, et al.. (2012). Regulatory Polymorphisms in β-Tubulin IIa Are Associated with Paclitaxel-Induced Peripheral Neuropathy. Clinical Cancer Research. 18(16). 4441–4448. 57 indexed citations

11.

Grabar, Petra Bohanec, Luis J. Leandro‐García, Lucía Inglada‐Pérez, et al.. (2012). Genetic Variation in the SLC19A1 gene and Methotrexate Toxicity in Rheumatoid Arthritis Patients. Pharmacogenomics. 13(14). 1583–1594. 24 indexed citations

12.

Cascón, Alberto, Luis J. Leandro‐García, Rocío Letón, et al.. (2011). Detection of the first gross CDC73 germline deletion in an HPT‐JT syndrome family. Genes Chromosomes and Cancer. 50(11). 922–929. 37 indexed citations

13.

García-Donás, Jesús, Emilio Esteban, Luis J. Leandro‐García, et al.. (2011). Single nucleotide polymorphism associations with response and toxic effects in patients with advanced renal-cell carcinoma treated with first-line sunitinib: a multicentre, observational, prospective study. The Lancet Oncology. 12(12). 1143–1150. 181 indexed citations

14.

Leskelä, Susanna, Carlos Jara, Luis J. Leandro‐García, et al.. (2010). Polymorphisms in cytochromes P450 2C8 and 3A5 are associated with paclitaxel neurotoxicity. The Pharmacogenomics Journal. 11(2). 121–129. 108 indexed citations

15.

Leskelä, Susanna, Luis J. Leandro‐García, Marta Mendiola, et al.. (2010). The miR-200 family controls -tubulin III expression and is associated with paclitaxel-based treatment response and progression-free survival in ovarian cancer patients. Endocrine Related Cancer. 18(1). 85–95. 168 indexed citations

16.

Leandro‐García, Luis J., Susanna Leskelä, Iñigo Landa, et al.. (2010). Tumoral and tissue‐specific expression of the major human β‐tubulin isotypes. Cytoskeleton. 67(4). 214–223. 208 indexed citations

17.

Cascón, Alberto, Guillermo Pita, Nelly Burnichon, et al.. (2009). Genetics of Pheochromocytoma and Paraganglioma in Spanish Patients. The Journal of Clinical Endocrinology & Metabolism. 94(5). 1701–1705. 93 indexed citations

18.

Rodríguez‐Antona, Cristina, Cristina Montero‐Conde, Lucía Inglada‐Pérez, et al.. (2009). Overexpression and activation of EGFR and VEGFR2 in medullary thyroid carcinomas is related to metastasis. Endocrine Related Cancer. 17(1). 7–16. 106 indexed citations

19.

López‐Jiménez, Elena, José M. de Campos, Iñigo Landa, et al.. (2008). SDHC mutation in an elderly patient without familial antecedents. Clinical Endocrinology. 69(6). 906–910. 28 indexed citations

20.

Marco, Roberto de, Luis J. Leandro‐García, Alberto Benguría, et al.. (2006). Gene expression variations during Drosophila metamorphosis in real and simulated gravity. cosp. 36. 3759. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact